 | Up a level |
Hammer, H; Kamm, CP; Salmen, A; Hoepner, R (2023). "Comparable Efficacy of SARS-CoV-2 mRNA Vaccines (BNT162b2 and mRNA-1273) in Fingolimod-Treated Patients with Multiple Sclerosis". Biomedical journal of scientific & technical research, 50(1) Biomedical Research Network+ 10.26717/BJSTR.2023.50.007885
Lehmann, I; Thaler, I; Verra, M; Luder, G; Damm, U; Wälti, C; Nyffeler, T; Vanbellingen, T; Kamm, CP (13 May 2019). A COMPREHENSIVE, TWO-MONTH CIRCUIT TRAINING IN PEOPLE WITH MULTIPLE SCLEROSIS - ADHERENCE AND SATISFACTION WITH THE STUDY INTERVENTION (Unpublished). In: World Confederation for Physical Therapy Congress 2019. Geneva. May 10-13.
